Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shoko Nakajima is active.

Publication


Featured researches published by Shoko Nakajima.


Pediatrics International | 2000

Hypothetical pathophysiology of acute encephalopathy and encephalitis related to influenza virus infection and hypothermia therapy

Shumpei Yokota; Tomoyuki Imagawa; Takako Miyamae; Shuichi Ito; Shoko Nakajima; Atsuo Nezu; Masaaki Mori

Abstract Background : To establish a treatment strategy for acute encephalopathy and encephalitis associated with influenza virus infection, the pathophysiology of the disease was investigated through manifestations and laboratory findings of patients.


Cytokine | 2009

Interleukin-6 inhibits early differentiation of ATDC5 chondrogenic progenitor cells

Shoko Nakajima; Takuya Naruto; Takako Miyamae; Tomoyuki Imagawa; Masaaki Mori; Shigeru Nishimaki; Shumpei Yokota

Interleukin (IL)-6 is a causative agent of systemic juvenile idiopathic arthritis (sJIA), a chronic inflammatory disease complicated with severe growth impairment. Recent trials of anti-IL-6 receptor monoclonal antibody, tocilizumab, indicated that tocilizumab blocks IL-6/IL-6 receptor-mediated inflammation, and induces catch-up growth in children with sJIA. This study evaluates the effects of IL-6 on chondrogenesis by ATDC5 cells, a clonal murine chondrogenic cell line that provides an excellent model for studying endochondral ossification at growth plate. ATDC5 cells were examined for the expression of IL-6 receptor and gp130 by fluorescence-activated cell sorting analysis. Recombinant murine IL-6 was added to ATDC5 cultures to observe cell differentiation, using a quantitative RT-PCR for the chondrogenic differentiation markers type II collagen, aggrecan, and type X collagen. To block IL-6, the anti-mouse IL-6 receptor monoclonal antibody MR16-1 was added. As a result, the cells expressed IL-6 receptor and gp130. The expression of chondrogenic differentiation marker gene was reduced by IL-6, but this was abrogated by MR16-1. We conclude that IL-6 inhibits early chondrogenesis of ATDC5 cells suggesting that IL-6 may affect committed stem cells at a cellular level during chondrogenic differentiation of growth plate chondrocytes, and that IL-6 may be a cellular-level factor in growth impairment in sJIA.


Pediatrics International | 2009

Survey of psychological support for bereaved families in Japan

Shigeru Nishimaki; Rumiko Higuchi; Shoko Nakajima; Takako Miyamae; Hiroaki Goto; Masaaki Mori; Shumpei Yokota

Background:  The aim of the present study was to investigate the current conditions of psychological support for the families of children who died suddenly of disease or accident.


Modern Rheumatology | 2009

Improvement of reduced serum cartilage oligomeric matrix protein levels in systemic juvenile idiopathic arthritis patients treated with the anti-interleukin-6 receptor monoclonal antibody tocilizumab

Shoko Nakajima; Takuya Naruto; Takako Miyamae; Tomoyuki Imagawa; Masaaki Mori; Shigeru Nishimaki; Shumpei Yokota


Modern Rheumatology | 2009

The role of heme oxygenase-1 in systemic-onset juvenile idiopathic arthritis

Akitaka Takahashi; Masaaki Mori; Takuya Naruto; Shoko Nakajima; Takako Miyamae; Tomoyuki Imagawa; Shumpei Yokota


Modern Rheumatology | 2013

Clinical analysis of 50 children with juvenile dermatomyositis

Takayuki Kishi; Takako Miyamae; Ryoki Hara; Shoko Nakajima; Tomoyuki Imagawa; Masaaki Mori; Shumpei Yokota


The Journal of Rheumatology | 2004

HLA-DRB1*15021 is the predominant allele in Japanese patients with juvenile dermatomyositis.

Noriaki Tomono; Masaaki Mori; Shoko Nakajima; Takako Miyamae; Shuichi Ito; Toshihiro Mitsuda; Shumpei Yokota


Japanese journal of clinical immunology | 2005

[A case of autoimmune hepatitis needed to be differentiated from EBV hepatitis, in that the histology of liver biopsy specimen was useful for diagnosis].

Shoko Nakajima; Hiroaki Umebayashi; Rumiko Kurosawa; Tomoyuki Imagawa; Shigeki Katakura; Masaaki Mori; Yuko Aihara; Shumpei Yokota; Tuyoshi Sogo; Ayano Inui; Tomoo Fujisawa; Norio Hanzawa


Japanese journal of clinical immunology | 2008

[Clinical features and laboratory findings in children with both anti-dsDNA and anti-U1-RNP antibody].

Takako Miyamae; Shuichi Ito; Hiroyuki Machida; Remi Ozawa; Rumiko Higuchi; Shoko Nakajima; Tomoyuki Imagawa; Tomoko Nakamura; Masaaki Mori; Yuko Aihara; Kenji Ohshige; Shumpei Yokota


Ryūmachi. [Rheumatism] | 2003

Effects of therapies on childhood systemic lupus erythematosus

Rumiko Kurosawa; Remi Umezawa; Yoshinori Kobayashi; Shoko Nakajima; Takako Miyamae; Shuichi Ito; Tomoyuki Imagawa; Shigeki Katakura; Masaaki Mori; Yukoh Aihara; Shumpei Yokota

Collaboration


Dive into the Shoko Nakajima's collaboration.

Top Co-Authors

Avatar

Shumpei Yokota

Yokohama City University

View shared research outputs
Top Co-Authors

Avatar

Masaaki Mori

Yokohama City University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Takako Miyamae

Yokohama City University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Shuichi Ito

Yokohama City University

View shared research outputs
Top Co-Authors

Avatar

Shigeki Katakura

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Noriaki Tomono

Yokohama City University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Takuya Naruto

Yokohama City University

View shared research outputs
Researchain Logo
Decentralizing Knowledge